Why the study?
Does transradial access reduce major access site-related bleeding complications and mortality compared to femoral access in high-risk patients undergoing PCI?
Does transradial access reduce major access site-related bleeding complications and mortality compared to femoral access in high-risk patients undergoing PCI?
Transradial access for PCI is associated with reduced major bleeding complications and mortality compared to femoral access, particularly in high-risk patients.
May support transradial preference in high-risk PCI; leaves open need for updated randomized confirmation.
Percutaneous coronary intervention (PCI) is the commonest form of revascularization in patients with coronary heart disease. The benefit of early invasive treatment with PCI in patients presenting with acute coronary syndromes are well accepted. Traditionally, PCI has been performed via the femoral access with significant risks for the development of access site-related bleeding complications. Increased international adoption of the transradial access site for PCI procedures has been shown to reduce such major access site-related bleeding complications and mortality, especially in the high-risk patient groups. We provide a brief overview of the historical perspective on transradial approach and the evidence supporting its use. We then discuss the current data supporting transradial access in high-risk populations and factors that have limited its adoption.
No takes yet. Share an insight, caveat, or question.
Khoo et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: